Semaglutide (Wegovy) for Weight Loss: In large clinical trials (the STEP trials), patients taking Wegovy combined with diet and exercise lost an average of 15% of their initial body weight over 68 weeks
The food and beverage giant is also trialling Full Factor, an on-the-go protein-rich RTD, under its GLP-1-oriented Vital Pursuit portfolio at select stores in the United States
In KFFs 2024 annual budget survey, 13 states under Medicaid fee-for-service contracts cover GLP-1s for obesity treatment, and most require prior authorization for prescription approval
While they praised the research for helping to create a real-world snapshot of how the drugs are affecting patients, they said that there is a lot of misunderstanding about gastroparesis and its risk to patients
Manufacturers can choose to collaborate with strong and reputable distributors to jointly develop sales strategies and marketing plans
DOI: 10.3389/fphys.2016.00594 45